Agilent Technologies, Inc. $A Stock Sold by Candriam S.C.A.

Candriam S.C.A. trimmed its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 19.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,088,839 shares of the medical research company’s stock after selling 263,389 shares during the quarter. Agilent Technologies accounts for 0.8% of Candriam S.C.A.’s portfolio, making the stock its 21st largest holding. Candriam S.C.A. owned approximately 0.39% of Agilent Technologies worth $188,303,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Bank of Nova Scotia acquired a new stake in shares of Agilent Technologies during the second quarter worth approximately $58,539,000. Dudley & Shanley Inc. raised its stake in shares of Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after acquiring an additional 14,300 shares during the last quarter. BIP Wealth LLC bought a new position in shares of Agilent Technologies in the second quarter valued at approximately $834,000. Sivia Capital Partners LLC acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $1,818,000. Finally, KBC Group NV boosted its holdings in shares of Agilent Technologies by 18.4% in the 2nd quarter. KBC Group NV now owns 81,883 shares of the medical research company’s stock worth $10,877,000 after acquiring an additional 12,719 shares in the last quarter.

Agilent Technologies Trading Up 1.7%

A stock opened at $174.79 on Friday. The company has a market cap of $49.28 billion, a P/E ratio of 34.41, a PEG ratio of 2.56 and a beta of 1.24. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $182.99. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The business has a fifty day moving average of $165.94 and a 200-day moving average of $137.20.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were given a dividend of $0.2550 per share. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies’s dividend payout ratio is presently 20.08%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. UBS Group increased their price target on Agilent Technologies from $165.00 to $180.00 in a research report on Tuesday, October 13th. Robert W. Baird lifted their price objective on Agilent Technologies from $180.00 to $195.00 and gave the company an “outperform” rating in a research report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft started coverage on Agilent Technologies in a research note on Monday, October 26th. They issued a “buy” rating and a $190.00 price objective on the stock. Royal Bank Of Canada boosted their price objective on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Finally, Citigroup increased their target price on Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Eighteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $181.45.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.